Merck has acquired AmpTec, a Hamburg, Germany-based, mRNA contract development and manufacturing organisation (CDMO), expanding its mRNA capabilities for vaccines, treatments and diagnostics. The deal strengthens Merck’s capabilities to develop...

Reach Separations enters purification alliance with NovAliX

Purification specialists Reach Separations and drug discovery contract research organisation (CRO), NovAliX, have entered into a unique alliance to develop supercritical fluid chromatography (SFC)...

Exploratory research project to develop novel protein expression systems via cell reprogramming

Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming...

View the Online Magazine

- Advertisement -

Launches

Expert group calls for urgent action as variance of prostate cancer care laid bare

The first analysis of its kind carried out the by the Let’s Talk Prostate Cancer Expert Group – an initiative organised and funded by...

Beckman Coulter launch SARS-CoV-2 IgM antibody test in countries accepting CE Mark

Beckman Coulter, a clinical diagnostics leader, has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The...

The Native Antigen Company launches range of SARS-CoV-2 specific antibodies

The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), suppliers of reagents that enable research into vaccines and diagnostics for emerging and...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

UK to receive further 2m doses of Moderna’s COVID vaccine candidate

Moderna has announced a supply agreement with the UK government for an additional 2 million doses of its COVID-19 vaccine candidate, mRNA-1273, to the...

COVAXX to deliver more than 140m COVID vaccine doses to emerging countries

COVAXX, a US company developing a multitope peptide-based vaccine to fight COVID-19, has advanced purchased commitments of more than 140 million doses of its...

Life sciences accelerator creates seventy new companies since inception

MediCity Glasgow, a multi-agency supported incubator & accelerator project, has helped create seventy new life sciences and med-tech companies in the last five years,...

Avacta launch COVID-19 laboratory test

Avacta Group is set to launch a high-performance test for the SARS-CoV-2 spike protein to support global efforts to combat COVID-19. Enzyme linked immunosorbent assays...

Approvals

COVID-19 Vaccine Moderna authorised in Europe

The European Commission has granted a conditional marketing authorisation (CMA) for COVID-19 Vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled...

Israeli authorises Moderna’s COVID-19 vaccine

Israel’s Ministry of Health (MOH) has given authorisation to import the Moderna’s COVID-19 vaccine in Israel. “Today’s authorisation is a landmark moment in our company’s...

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with vaccinations now taking place. The UK Medicines and Healthcare products Regulatory Agency...

US approves Rhizen’s new drug application to study oral inhibitor against COVID

Regulators in the US have approved Rhizen Pharmaceuticals’ Investigational New Drug (IND) application to study its oral DHODH inhibitor for SARS-CoV-2 infection. The company’s initial...

Pfizer & BioNTech achieve first authorisation for vaccine to combat COVID-19

Pfizer and BioNTech have secured temporary authorisation for emergency use from the UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for the duo’s COVID-19...

EMA validates application for Mercks’ Tepotinib for review

The European Medicines Agency (EMA) has validated Merck’s application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC)...

Manufacturiung

Finance

Research & Development
Latest

Reach Separations enters purification alliance with NovAliX

Purification specialists Reach Separations and drug discovery contract research organisation (CRO), NovAliX, have entered into a unique alliance to develop supercritical fluid chromatography (SFC)...

Exploratory research project to develop novel protein expression systems via cell reprogramming

Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming...

First COVID patients enrolled in AM-Pharma’s Phase III trial

The first patients with COVID-19 infection and sepsis-associated acute kidney injury (SA-AKI) have been enrolled in AM-Pharma’s Phase III REVIVAL pivotal trial in an...

Avacta enters license agreement with POINT Biopharma

Avacta Group has entered into a license agreement with Canada’s POINT Biopharma to provide access to the former’s pre|CISION technology for the development of...

Positive results for aTyr Pharma’s COVID-19 candidate

San Diego biotherapeutics company, aTyr Pharma, has reported positive topline results from its Phase 2 clinical trial of its lead therapeutic candidate, ATYR1923, in...

Appointments

- Advertisement -